The high expression of Galectin-1 is associated with the migration and invasion of gastric cancer cells and poor prognosis of patients with prostate cancer (Shih et al., 2018) and hepatocellular carcinoma (Tsai et al., 2022). This evidence concerns the gene LGALS1 and prostate cancer.